HABA Laboratories, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
850.00
635.00
-1,843.00
-548.00
-266.00
283.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
434.00
880.00
-688.00
37.00
1,062.00
36.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,237.00
1,621.00
-587.00
55.00
1,714.00
534.00
Cash Flow from Investing Activities
484.00
-147.00
-441.00
-214.00
-216.00
-925.00
Cash Flow from Financing Activities
-780.00
-689.00
171.00
-676.00
-1,512.00
825.00
Net Cash Inflow / Outflow
940.00
784.00
-858.00
-833.00
-12.00
435.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
1.00
2.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of HABA Laboratories, Inc.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
850.049
2200.999
-1,350.00
-61.38%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
434.326
-1184.342
1,618.00
136.67%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1237.182
1786.827
-549.00
-30.76%
Cash Flow from Investing Activities
484.538
-3326.986
3,810.00
114.56%
Cash Flow from Financing Activities
-780.751
666.749
-1,446.00
-217.10%
Net Cash Inflow / Outflow
940.969
-870.67
1,810.00
208.07%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
2.74
-2.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -23.68% vs 375.72% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
1,237.18
1,621.01
-23.68%






